[1] Storm D R, Rosenthal K S, Swanson P E. Polymyxin and related peptide antibiotics[J]. Annu Rev Biochem ,1977, 46(6):723-763. [2] Brown J M, Dorman D C, Roy L P. Acute renal failure due to overdosage of colistin[J]. Med J Aust, 1970, 2(20):923-924. [3] Koch-Weser J, Sidel V W, Federman E B, et al. Adverse effects of sodium colistimethate Manifestations and specific reaction rates during 317 courses of therapy[J]. Ann Intern Med,1970, 72(6):857-868. [4] Levin A S, Barone A A, Penco J, et al. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii[J]. Clin Infect Dis, 1999, 28(5):1008-1011. [5] Garnacho-Montero J, Ortiz-Leyba C, Jimenez-Jimenez F J, et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator- associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP[J]. Clin Infect Dis, 2003,36(9):1111-1118. [6] Akajagbor D S, Wilson S L, Shere-Wolfe K D, et al. Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at atertiary care medical center[J]. Clin Infect Dis, 2013,57(9):1300-1303. [7] Phe K, Lee Y, McDaneld P M, et al. In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy[J].Antimicrob Agents Chemother,2014,58(5):2740-2746. [8] Ouderkirk J P, Nord J A, Turett G S, et al. Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria[J]. Antimicrob Agents Chemother, 2003,47(8):2659-2662. [9] Sobieszczyk M E, Furuya E Y, Hay C M, et al. Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections[J]. J Antimicrob Chemother, 2004,54(2):566-569. [10] Florescu D F, Qiu F, McCartan M A, et al. What is the efficacy and safety of colistin for the treatment of ventilator-associated pneumonia? A systematic review and meta-regression[J].Clin Infect Dis, 2012,54(5):670-680. [11] Falagas M E, Kasiakou S K. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies[J]. Crit Care, 2006,10(1):R27. |